News
1don MSN
Eli Lilly shares are now positive for the year, up 10% since the start of January.
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
Why is Mounjaro attracting attention? Reuters reports that India's growing obesity crisis makes it a key market, expected to become the second-largest by 2050. Mounjaro, with its competitive pricing — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results